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Abstract 
Gallbladder carcinoma is the most common
biliary tract tumor and the fifth most common
gastrointestinal tract cancer. The prognosis of
gallbladder carcinoma is poor and less than
5% of the patients are still alive five years
postoperatively. Gallbladder specimens  were
obtained  during  surgical  operations  per-
formed in eleven patients for resection of a
gallbladder carcinoma, and during five autop-
sies (control cases selected among patients
who  died  from  for  other  causes,  excluding
those  suffering  from  biliary  or  hepatic  dis-
eases).  Immunohistochemical  characteriza-
tion and distribution of neurotrophins, with
their respective receptors, were analyzed. The
actual role played by these neurotrophic fac-
tors in the general regulation, vascular per-
meability,  algic  responsiveness,  release  of
locally  active  substances  and  potential
tumorigenesis in the gallbladder and biliary
ducts  compartment  remains  controversial.
Our study revealed an increased immunohis-
tochemical expression of NGF and TrKA in the
epithelium and in the epithelial glands of the
gallbladder carcinoma together with an evi-
dent immunoreactivity for BDNF in the same
neoplastic areas. An evident immunoreactivi-
ty for NGF, TrKA and BDNF was observed in
control  specimens  of  gallbladder  obtained
during  autopsies,  whereas  a  weak  or  quite
absent immunoreactivity was observed in the
same specimens for NT4, TrKC and p75. On
the contrary an appreciable immunoreactivity
for p75 was observed in the specimens har-
vested from patients with gallbladder carcino-
ma. We also investigated the expression of
some known tumor markers such as  MIB-1
(anti Ki-67), CD34 and CA15-3, to identify a
possible correlation between the expression
of these molecular factors and the prognosis
of gallbladder carcinoma. They resulted high-
ly expressed in the stroma (CD34 and CA 15-
3)  and  in  the  epithelium/epithelial  glands
(MIB-1) of the neoplastic areas and appeared
to be almost absent in the control cases, sug-
gesting that these markers, taken together,
could be adopted as a panel of prognostic fac-
tors in the evaluation of the gallbladder carci-
noma.
Introduction
Carcinoma of the gallbladder is the most
common biliary tract tumor and the fifth most
common  gastrointestinal  tract  cancer.  The
symptoms of gallbladder carcinoma are non-
specific, but the risk is significantly higher in
cholelithiasis.  The  non-specificity  of  symp-
toms is responsible for delayed diagnosis: in
fact,  this  tumor  is  usually  identified  at  an
advanced stage when it has already become
unresectable.
1 The  prognosis  of  gallbladder
carcinoma is poor and less than 5% of the
patients are still alive five years postopera-
tively. The majority of patients who live longer
than five years are usually those in whom the
carcinoma was first diagnosed at microscopic
examination of their gallbladders which were
removed for a presumed benign disease.
1 The
major route of spread of gallbladder cancer is
locoregional: in fact, it usually extends direct-
ly into the liver and porta hepatis resulting in
narrowing  or  obstruction  of  the  common
hepatic or right hepatic duct.
1
The liver and the biliary ducts are innervat-
ed by both sympathetic and parasympathetic
nerves, whose fibers are located around the
hepatic artery, portal vein, intrahepatic and
extrahepatic  biliary  ducts.
2 Various  neuro-
transmitters,  as  NPY,  CGRP,  VIP,  somato-
statin,  enkephalin  and  bombesin,  are
involved  in  regulating  the  functions  of  the
bile ducts, portal tract and arterial vessels of
the hepatic compartment, with possible mul-
tiple effects on intrahepatic hemodynamics.
3,4
Biliary  ducts  are  the  target  of  cholan-
giopathies, defined by a dysregulation of the
equilibrium between cell growth and survival,
with a progressive impairment of the prolifer-
ative response against duct injury leading to a
functional liver failure at the end stage.
2 The
possible malignant transformation of cholan-
giocytes leads to cholangiocarcinoma, which
may affect not only the biliary ducts, but also
the  gallbladder.  These  lesions,  often  diag-
nosed at late stages and with an increasing
incidence worldwide, are characterized by a
limited and unsatisfactory surgical option as
well as by a minimal response to the conven-
tional chemotherapy.
5 We decided to investi-
gate the localization and the distribution of
neurotrophins and their receptors in this con-
troversial area. Neurotrophins (NTs) consti-
tute a family of dimeric proteins working as
polypeptidic  growth  factors  and  acting  like
extracellular  ligands.  NTs,  including  NGF,
BDNF, NT-3, NT-4, are involved in neuronal
cell development, differentiation, survival and
functional activities. Neurotrophins are also
involved  in  the  modulation  of  adult  central
nervous system functions and organization,
as well as in the neural control of different
activities related to vegetative innervation of
several  organs.
6,7 Our  previous  observations
regarding the localization and possible roles
in  different  non-neuronal  tissues  such  as
those of the lymphoid, lung and prostate tis-
sues
8,9 encouraged us to ascertain any possi-
ble involvement of NTs in the biliary ducts,
both in physiological and pathological condi-
tions  (cholangiocarcinomas).  Our  study
investigated the immunohistochemical local-
ization  and  expression  of  NTs  and  their
receptors both in normal autoptic specimens
of normal gallbladder and in the neoplastic
tissue obtained during surgical operations for
the resection of a gallbladder carcinoma. Our
interest  was  also  focussed  on  some  known
tumor  markers  such  as  MIB-1  (Ki-67  anti-
gen),  CD34  and  CA15-3  that  are  becoming
significant in the diagnosis and evaluation of
tumor but whose role in the gallbladder carci-
noma has not yet been clearly established.
10-12
We decided to describe the possibility of a cor-
relation between the above mentioned tumor
markers and the expression of NTs (and their
receptors)  to  clarify  the  physiopathological
mechanisms involved in gallbladder carcino-
ma development, and to identify a panel of
reliable prognostic factors in the evaluation
of tumor staging .
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Materials and Methods
Patients
Surgical  operations  were  performed  on
eleven adult patients (age range 45-75 years)
for the resection of a gallbladder carcinoma.
Specimens  harvested  from  the  above  men-
tioned cases, as well as five other specimens
(control cases) obtained during autopsies or
during surgical resections performed for gall-
bladder  lithiasis,  were  then  processed  for
immunohistochemical  analysis.  Experiments
were performed in compliance with the Italian
laws and guidelines concerning the patients
informed  consent.  The  following  molecules
were investigated: nerve growth factor (NGF),
brain derived neurotrophic factor (BDNF), NT-
3, NT-4 and the neurotrophin receptors tyro-
sine  kinase  A  (TrKA),  tyrosine  kinase  B
(TrKB), tyrosine kinase C (TrKC) and p75, as
well  as    MIB-1  (Ki-67  antigen),  CD34  and
CA15-3.
Immunohistochemical analysis. 
Small fragments of gallbladder tissue were
washed  in  PBS,  fixed  in  10%  formalin  and
embedded in paraffin according to a standard
procedure. Serial 4 μm thick sections were cut
using a rotary microtome, mounted on gelatin-
coated slides and processed for immunohisto-
chemistry. In order to study the immunolocal-
ization of neurotrophins and their own recep-
tors,  the  following  antibodies  were  used:  a)
rabbit  anti-nerve  growth  factor  (anti-NGF)
polyclonal antibody (Santa Cruz, CA, USA). It
displayed <1% cross-reactivity against recom-
binant human NT-3, NT-4 and BDNF; b) rabbit
anti-tyrosine kinase A (anti-TrKA) polyclonal
antibody (Santa Cruz). It recognized an epi-
tope corresponding to amino acids 763 to 777,
mapping adjacent to the carboxy-terminus of
human TrKA p140; c) goat polyclonal antibody
to human p75 NT receptor (Santa Cruz). It rec-
ognized the amino acid sequence mapping the
carboxy-terminus of the p75 NT receptor pre-
cursor of human origin; d) rabbit anti-brain
derived neurotrophic factor (anti-BDNF) poly-
clonal antibody (Santa Cruz). It recognized the
amino-terminal of mouse BDNF; e) rabbit anti-
tyrosine kinase B (anti-TrKB) polyclonal anti-
body (Santa Cruz). It recognized an epitope
corresponding  to  amino  acids  794  to  808  of
mouse TrKB p145; f) rabbit anti-neurotrophin
3  (anti-NT-3)  polyclonal  antibody  (Santa
Cruz). It was raised against the amino-termi-
nal of mouse NT-3; g) rabbit polyclonal anti-
tyrosine kinase C (anti-TrKC) antibody (Santa
Cruz). It recognized an epitope corresponding
to  amino  acids  798  to  812  of  porcine  TrKC
p140; h) mouse monoclonal anti-human MIB-1
(Ki-67 antigen; Dako Cytomation, Denmark).
The  MIB-1  antibody  recognizes  native  Ki-67
antigen and recombinant fragments of the Ki-
67  molecule;
13 i)  monoclonal  mouse  anti-
human  CA15-3  antibody  (Dako  Cytomation,
Denmark) reacts with the DF-3 antigen, a high
molecular weight (300 kD) mucin-like glyco-
protein, present on the apical borders of secre-
tory mammary epithelial cells. The binding site
for monoclonal antibody CA15-3 involves a gly-
cosidic linkage between carbohydrate and pro-
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Figure 1. Micrographs of NGF immunostaining in human normal gallbladder (1A) and
Gallbladder Carcinoma (1B). NGF shows an evident immunoreactivity in the epithelial
glands (g) and in the blood vessels (v), weak in the epithelium (e), and in the normal gall-
bladder (1A). In gallbladder carcinoma NGF is highly detectable in the epithelium (e) and
stroma (s), only moderate in in the blood vessels (v) (1B).
Figure 2. Micrographs of TrKA immunostaining in human normal gallbladder (2A) and
Gallbladder Carcinoma (2B). In the normal gallbladder TrKA shows an evident reaction
in the epithelium (e)/epithelial glands (g) but an absence in the blood vessels (v) and stro-
ma  (s)  (2A). TrKA  expression  in  gallbladder  carcinoma  is  marked  in  the  epithelium
(e)/epithelial glands (g) but absent in blood vessels (v) and stroma (s) (2B).
Figure 3. Micrographs of p75 immunostaining in human normal gallbladder (3A) and
Gallbladder Carcinoma (3B). P75 expression is generally absent in normal gallbladder
(3A), evident in the epithelium (e) and stromal compartment (s), but only moderate in
blood vessels (v) (3B).[page 52] [European Journal of Histochemistry 2010; 54:e10]
tein moieties on the DF3 antigen; l) mouse
monoclonal anti-CD34 (Abcam plc, Cambridge,
UK), which reacts with a protein present on
endothelial cells and hematopoietic progenitor
cells.  The  antibody  recognizes  a  neu-
raminidase sensitive epitope on endothelium
in vivo, particularly on small vessels and neo-
formed  capillaries  and  developing  vascular
structures  in  embryonal  structures.  CD34  is
highly  expressed  on  hematopoietic  progeni-
tors, as well as on endothelial cells, brain, and
testis.  Staining  for  CD34  has  been  used  to
measure angiogenesis, which reportedly pre-
dicts tumor recurrence.
Incubation with primary antibodies was per-
formed overnight at 4°C at a final concentra-
tion of 2-5 μg/mL. Optimal antisera dilutions
and incubation times were assessed in a series
of preliminary experiments. After exposure to
the  primary  antibodies,  slides  were  rinsed
twice  in  phosphate  buffer  and  incubated  90
min at room temperature with the appropriate
secondary antibody conjugated to horseradish
peroxidase (HRP) at final dilution 1:100. The
secondary antibody-HRP linked against rabbit
immunoglobulins  was  purchased  from
Boehringer  (Mannheim  GmbH,  Mannheim,
Germany),  while  secondary  antibodies-HRP
linked against mouse and goat immunoglobu-
lins were from Sigma (Sigma Chemicals Co,
St. Louis, MO, USA). After a further wash with
phosphate  buffer,  slides  were  treated  with
0.05% 3,3-diaminobenzidine (DAB) and 0.1%
H2O2. 
Finally, sections were counterstained with
Mayer's  hematoxylin  and  observed  using  a
light microscope. 
To  block  endogenous  peroxidase  activity,
slides were pretreated with 3% H2O2, whereas
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Figure 4   – 5. Micrographs of BDNF immunostaining in human normal gallbladder (4A –
5A) and Gallbladder Carcinoma (4B – 5B). BDNF expression is evident in epithelium
(e)/epithelial glands (g) and moderate in stromal compartment (s) (4A – 5A). In gallblad-
der carcinoma BDNF shows a marked expression in the epithelium (e) and stroma (s),
moderate in the epithelial glands (g) and weak in blood vessels (v) (4B – 5B).
Figure 6. Micrographs of TrKB immunostaining in human normal gallbladder (6A) and
Gallbladder Carcinoma (6B). TrKB expression is moderate in the stroma (s) and weak in
the epithelium (e), and in normal gallbladder (6A), while it is evident in the stroma (s) in
gallbladder carcinoma (6B).
Table 1. Human normal gall bladder.
Epithelium Epithelial  Blood  Stroma
glands vessels
NGF ±+ +/++ -
TrKA ++ ++ --
P75 -- - -
BDNF ++ ++ -+
TrKB ±- - +
NT3 ++ ++ ++ ++
NT4 -- - -
TrKC ±± - ±
MIB -  -- -
CD34 -- - -
CA15-3 -- - -
±, weak immunoreactivity;  +, moderate immunoreactivity; ++, rele-
vant immunoreactivity, +++, strong immunoreactivity.
Table 2. Gallbladder carcinoma.
Epithelium Epithelial  Blood  Stroma
glands vessels
NGF ++ ±± ++
TrKA +++ +++ --
P75 ++ -+ ++
BDNF +++ +± +++
TrKB -- - +/++
NT3 ++ ++ ++ ++
NT4 -- - ±
TrKC -- - ±
MIB ++ +++ ±+
CD 34 -- - ++
CA15-3 -- - ++
±, weak immunoreactivity;  +, moderate immunoreactivity; ++, rele-
vant immunoreactivity, +++, strong immunoreactivity.[European Journal of Histochemistry 2010; 54:e10] [page 53]
the non-specific binding of immunoglobulins
was prevented by adding 3% fetal calf serum to
the  incubation  medium.  Negative  control
experiments were done: i) by omitting the pri-
mary antibody; ii) by substituting the primary
antibody with an equivalent amount of non-
specific immunoglobulins; iii) by pre-incubat-
ing  the  primary  antibody  with  the  specific
blocking peptide (antigen/antibody = 5 accord-
ing to supplier's instructions). The intensity of
immune reaction was assessed microdensito-
metrically  by  an  IAS  2000  image  analyzer
(Delta Sistemi, Rome, Italy) connected via a
TV camera to the microscope. The system was
calibrated taking the background obtained in
sections  exposed  to  non-immune  serum  as
zero. Ten 100 μm
2 areas were delineated in
each section by a measuring the diaphragm.
Quantitative  data  of  the  intensity  of  the
immune staining were analyzed statistically by
analysis  of  variance  (ANOVA)  followed  by
Duncan's multiple range test as a post hoctest. 
The  parameter  examined  by  quantitative
analysis was the distribution and the intensity
of the immunoreaction. The registered values
were  transformed  into  a  single  number
expressed as conventional unit, including the
standard deviation. This number can be read
on  the  display  of  the  Quantimet  500  image
analyzer.
Results
Immunohistochemistry
Immunoreactivity  for  neurotrophins  and
their own receptors, as well as MIB-1, CD34
and CA15-3, was observed both in the normal
gallbladder and in the neoplastic tissue and the
results  are  described  below  (see  Table  I-II).
The sections harvested from normal gallblad-
der generally revealed an evident immunore-
activity for NGF in the epithelial glands and in
blood vessels (Figure 1A). TrkA immunoreac-
tivity  was  strongly  marked  in  the  epithelial
glands and in the epithelium layer (Figure 2A).
A  total  absence  of  immunoreactivity  for  the
p75NTR was demonstrated in all the examined
structures (Figure 3A). BDNF immunoreactiv-
ity  was  extremely  evident    in  the  epithelial
glands and in the epithelium (Figure 4A-5A)
while in the same compartments we observed
a weak reaction for TrkB (Figure 6A). Marked
immunoreactivity was demonstrated for NT-3
in the epithelium, in the stroma, in the epithe-
lial  glands  and  in  the  blood  vessels  (Figure
7A).  NT-4  in  the  previous  compartments
(Figure 8A) was characterized by the absence
of  immunoreactivty.  TrkC  immunoreactivity
was poorly appreciable in the stroma and in
epithelium/epithelial glands (Figure 9A). MIB-
1, CD34 and CA 15-3  immunoreactivity were
generally absent in all the control specimens
(figure not shown).
On the other hand, the gallbladder carcino-
ma samples revealed a relevant immunoreac-
tivity for NGF in the epithelium and in the stro-
ma,  and  an  evident,  to  a  lesser  degree
immunoreactivity, in the epithelial glands and
in  the  blood  vessels  (Figure  1B).  TrkA
immuno-reactivity was strongly marked in all
the compartments with the exception of blood
vessels and stroma, with a maximal expression
in  the  epithelium  (Figure  2B).  An  evident
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Figure 7. Micrographs of NT-3 immunostaining in human normal gallbladder (7A) and
Gallbladder Carcinoma (7B). NT-3 is evident in all the compartments analysed (epitheli-
um (e)/epithelial glands (g), blood vessels (v), stroma (s)) in normal gallbladder (7A), as
well as in gallbladder carcinoma (7B).
Figure 8. Micrographs of NT-4 immunostaining in human normal gallbladder (8A) and
Gallbladder Carcinoma (8B). NT-4 is generally absent in the normal gallbladder in the
compartments described (8A), but weak in the stroma (s) in the gallbladder carcinoma
(8B).
Figure 9. Micrographs of TrKC immunostaining in human normal gallbladder (9A) and
Gallbladder Carcinoma (9B). TrKC is weakly expressed in the epithelium (e)/epithelial
glands (g) and stroma (s) in normal gallbladder (9A), but also weak only in the stroma (s)
of gallbladder carcinoma (9B).[page 54] [European Journal of Histochemistry 2010; 54:e10]
immunoreactivity for the p75NTR was visible
in the stroma and in the epithelium, but mod-
erate in the blood vessels and absent in the
epithelial  glands  (Figure  3B).  BDNF
immunoreactivity  was  extremely  evident    in
the stroma and in the epithelium, moderate in
the epithelial glands and poorly appreciable in
the blood vessels (Figure 4B – 5B). A marked
immunoreaction for TrkB was observed  only
in  the  stromal  compartment  (Figure  6B).
Marked immunoreactivity was showed by NT-3
in  the  epithelium,  stroma,  epithelial  glands
and in the blood vessels (Figure 7B).  NT-4
(Figure 8B) was characterized by the absence
of immunoreactivity in the previous compart-
ments with the exception for the stroma which
appeared  weakly  positive  (Figure  8B).  TrkC
immunoreactivity was only poorly appreciable
in the stroma (Figure 9B). MIB-1  immunore-
activity was marked in the epithelium/epithe-
lial glands, moderate in the stroma and very
weak in the blood vessels (Figure 10). CD 34
(Figure 11) and CA15-3 (Figure 12) immuno-
reactivity  was  marked  in  the  stroma  and
absent in the remaining compartments exam-
ined.
Discussion
NGF plays an inflammatory role,
14 probably
due to the direct action of NGF on mast cells
and sensory neurones, as proposed by Woolf.
15
Neurotrophins  (NTs)  are  neurotrophic  sig-
nalling  polypeptides  which  include  nerve
growth factor (NGF), brain derived growth fac-
tor  (BDNF),  neurotrophin-3  (NT-3),  NT-4/5
and NT-6, the latter apparently being specific
to fish.
16The biological effects of NTs are medi-
ated by the binding with two families of mem-
brane  receptors,  the  high  affinity  tyrosine
kinase  (TrK)  and  low  affinity  p75  receptor
(p75NT receptor).
6 TrKA is specifically activat-
ed by NGF, whereas TrKB and TrKC are prima-
rily receptors for BDNF and NT-3 respectively.
6
The physiological role of NTs in the develop-
ment,  maintenance  and  regeneration  of  the
sympathetic and sensory nervous system has
been  well  established
6,16 and  NGF  mainly
induces differentiation and decreases growth
rate in a variety of neoplastic cells of neuro-
genic and non-neurogenic origin.
17 Rasi et al.
demonstrated that NGF was highly expressed
not only in hepatocarcinoma (HCC) but also in
early  preneoplastic  lesions,  suggesting  that
NGF  may  have  a  role  in  the  progression  of
HCC.
18,19 We have investigated the possible role
of NTs in the physiopathology of the gallblad-
der,  especially  in  carcinoma  specimens,
together with the expression profile analysis of
some tumor markers such as MIB-1 (anti Ki-
67), CD34 and CA15-3 whose role has been
ascertained, but not clearly defined, in previ-
ous reports.
10-12 Ki-67 expression appears to be
a good diagnostic indicator for gallbladder car-
cinoma but not a prognostic factor for survival
in  patients  with  gallbladder  carcinoma.
10
Immunoreactivity for MIB-1 antigen is low in
benign lesions such as chronic cholecystitis or
hyperplasia  when  compared  with  gallbladder
carcinoma,  suggesting  that  epithelial  hyper-
plasia  with  increased  cellular  proliferative
activity plays an important role in carcinogen-
esis.  In  in  situ gallbladder  carcinoma  MIB-1
expression  was  low  compared  with  lesions
showing more advanced gallbladder wall infil-
tration.
20,21 Shrestha et al. found that patients
with  gallbladder  carcinoma  expressing  high
Ki-67 immunoreactivity had a worse postoper-
ative  prognosis  than  those  who  did  not,
although there was no relationship between
Ki-67 immunoreactivity and patient survival.
20
Our results suggest a marked expression of its
immunoreactivity  within  the  epithelium/
epithelial glands of patients affected by gall-
bladder  carcinoma,  which  partially  concords
with the results described by Hidalgo Grau et
al.,
10 confirming  that  epithelial  hyperplasia
with increased epithelial glands cellular prolif-
erative  activity  plays  a  direct  role  in  the
tumorigenesis process.
10 In fact, although MIB-
1  (Ki-67  antigen)  cannot  be  individually
assumed to be a reliable prognostic marker,
the consistent immunoreaction level observed
in  the  epithelial  layer  and  in  the  epithelial
glands of neoplastic specimens (compared to
the total absence detected in the control cases)
may be considered an important factor in the
morphological  differential  diagnosis  of  gall-
bladder clinical features. CD34 antigen reveals
only an appreciable immunoreactivity in the
stromal compartment of neoplastic specimens,
according  to  the  work  of  Tanaka,
12 which
demonstrates that immunostaining for CD34
is negative, both in controls cases and in gall-
bladder  cancer  cells  more  specifically,  since
hematopoietic progenitor cells may differenti-
ate into hepatic progenitor cells, hepatic pro-
genitor cells can be identified by a hematopoi-
etic stem cell marker, CD34, before they differ-
entiate into hepatoblasts.
12 Thus, we may con-
firm that CD34 is not a significant prognostic
marker for evaluating the clinicopathological
progression of gallbladder carcinoma. 
Concerning the prognostic value of CA15-3,
we may affirm that the sensitivity of this mark-
er is more pronounced compared to MIB-1 and
CD34.  In  fact,  as  Shukla’s  study,
11 CA15-3
appears to be a reliable marker for discriminat-
ing gallbladder carcinomas from cholelithiasis
cases, but it is less sensitive when used indi-
vidually in gallbladder carcinoma. 
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Figure 10. Micrographs of MIB-1 immunostaining in gallbladder carcinoma. MIB-1 is markedly expressed in the epithelial glands (g),
appreciable in epithelium layer (e), moderate in the stroma (s) and weak in the blood vessels (v) of the neoplastic area.
Figure 11. Micrographs of CD34 immunostaining in gallbladder carcinoma. CD34 is clearly detectable only in the stromal compart-
ment (s) of the neoplastic area.
Figure 12. Micrographs of CA15-3 immunostaining in gallbladder carcinoma. CA15- 3 is only clearly visible in the stromal compart-
ment (s) of the neoplastic area.[European Journal of Histochemistry 2010; 54:e10] [page 55]
To conclude, we have demonstrated that in
gallbladder carcinoma an increased expression
of NGF, TrKA and BDNF is clearly visible, sug-
gesting a direct role of these neurotrophic fac-
tors in the transformation and progression of
neoplastic cells of the gallbladder tissue. We
also  investigated  the  expression  of  MIB-1,
CD34  and  CA  15  -3  and  our  results  showed
that, taken individually, they can be useful in
the differential diagnosis of gallbladder clini-
cal  features,  discriminating  patients  with
primitive  gallbladder  carcinoma  from  those
with cholelithiasis, but when considered as a
whole, (especially MIB-1 and CA 15- 3) they
can represent a significant panel of prognostic
factors, for evaluating the clinico-pathological
progression of gallbladder carcinoma.
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